Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein.
Severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) is known to take an endosomal pathway for cell entry; however, it is thought to enter directly from the cell surface when a receptor-bound virion spike (S) protein is affected by trypsin, which induces cleavage of the S protein and activates its fusion potential. This suggests that SARS-CoV bearing a cleaved form of the S protein can enter cells directly from the cell surface without trypsin treatment. To explore this possibility, we introduced a furin-like cleavage sequence in the S protein at amino acids 798 to 801 and found that the mutated S protein was cleaved and induced cell fusion without trypsin treatment when expressed on the cell surface. Furthermore, a pseudotype virus bearing a cleaved S protein was revealed to infect cells in the presence of a lysosomotropic agent as well as a protease inhibitor, both of which are known to block SARS-CoV infection via an endosome, whereas the infection of pseudotypes with an uncleaved, wild-type S protein was blocked by these agents. A heptad repeat peptide, derived from a SARS-CoV S protein that is known to efficiently block infections from the cell surface, blocked the infection by a pseudotype with a cleaved S protein but not that with an uncleaved S protein. Those results indicate that SARS-CoV with a cleaved S protein is able to enter cells directly from the cell surface and agree with the previous observation of the protease-mediated cell surface entry of SARS-CoV.
Watanabe
Rie
R
Department of Virology III, National Institute of Infectious Diseases, Murayama Branch, 4-7-1 Gakuen, Mushai-Murayama, Tokyo 208-0011, Japan.
Matsuyama
Shutoku
S
Shirato
Kazuya
K
Maejima
Masami
M
Fukushi
Shuetsu
S
Morikawa
Shigeru
S
Taguchi
Fumihiro
F
D002459:Cell Fusion; D011992:Endosomes / Q000821:virology; D006367:HeLa Cells; D006801:Humans; D008562:Membrane Glycoproteins / Q000502:physiology*; D010196:Pancreatic Elastase / Q000502:physiology; D045473:Severe acute respiratory syndrome-related coronavirus / Q000502:physiology*; D064370:Spike Glycoprotein, Coronavirus; D014759:Viral Envelope Proteins / Q000502:physiology*
D008562:Membrane Glycoproteins; D064370:Spike Glycoprotein, Coronavirus; D014759:Viral Envelope Proteins; C578557:spike glycoprotein, SARS-CoV; C578553:spike protein, mouse hepatitis virus; D010196:Pancreatic Elastase
Virology. 1998 May 10;244(2):483-94
9601516
Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60
15150417
Virology. 2006 Jul 5;350(2):358-69
16519916
J Virol. 2005 Feb;79(3):1743-52
15650199
Virology. 2001 Aug 1;286(2):263-75
11485395
J Virol. 2006 Jun;80(12):5768-76
16731916
J Virol. 1985 Dec;56(3):904-11
2999443
Science. 2005 Jun 10;308(5728):1643-5
15831716
Cell. 1998 May 29;93(5):681-4
9630213
Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12543-7
16116101
Science. 2003 May 30;300(5624):1394-9
12730500
Virology. 1997 Jan 6;227(1):215-9
9007076
J Virol. 2004 Oct;78(19):10328-35
15367599
Microbiol Mol Biol Rev. 2005 Dec;69(4):635-64
16339739
J Virol. 2003 Feb;77(4):2530-8
12551991
J Mol Biol. 2003 Aug 29;331(5):991-1004
12927536
Protein Eng Des Sel. 2004 Jan;17(1):107-12
14985543
Microbiol Immunol. 2008 Feb;52(2):118-27
18380809
J Virol. 2007 Oct;81(19):10758-68
17626088
J Virol. 1994 Aug;68(8):5216-24
7913510
Nature. 2003 Nov 27;426(6965):450-4
14647384
Biochem Biophys Res Commun. 2005 Jan 21;326(3):554-63
15596135
J Virol. 2005 Jun;79(11):7195-206
15890958
Biochem Biophys Res Commun. 2003 Dec 26;312(4):1159-64
14651994
J Virol. 2008 Jan;82(1):588-92
17942557
J Virol. 2006 Sep;80(17):8639-52
16912312
J Virol. 1994 Sep;68(9):5403-10
7520090
Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11876-81
16081529
Infect Immun. 1982 Feb;35(2):515-22
6173324
Eur J Pharmacol. 2002 Sep 6;451(1):1-10
12223222
Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4240-5
15010527
J Gen Virol. 2005 Aug;86(Pt 8):2269-2274
16033974
J Gen Virol. 2000 Dec;81(Pt 12):2867-2871
11086117
J Virol. 1991 Apr;65(4):1916-28
1848311
J Gen Virol. 1975 Oct;29(1):25-34
171335
Annu Rev Biochem. 2001;70:777-810
11395423
J Virol. 2006 Jul;80(14):6794-800
16809285
J Virol. 2003 Aug;77(16):8801-11
12885899
J Virol. 2004 May;78(9):4552-60
15078936
Science. 2003 May 30;300(5624):1399-404
12730501
J Virol. 2008 Sep;82(17):8887-90
18562523